Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer-Reference-Cited by-同舟云学术

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer

Published:2004-04-06 Issue:9 Volume:90 Page:1740-1746
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Batista N,Perez-Manga G,Constenla M,Ruiz A,Carabantes F,Castellanos J,Gonzalez Barón M,Villman K,Söderberg M,Ahlgren J,Casinello J,Regueiro P,Murias A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6601784.pdf

Reference31 articles.

1. Abrams JS, Vena DA, Baltz J, Adams J, Montello M, Christian M, Onetto N, Desmond-Hellmann S, Canetta R, Friedman MA, Arbuck SG (1995) Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial. J Clin Oncol 13: 2056–2065

2. Blum JL (2001) The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancer. Oncologist 6: 56–64

3. Blum JL, Dieras V, Lo Russo PM, Horton J, Rutman O, Buzdar A, Osterwalder B (2001a) Multicenter, phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients. Cancer 92: 1759–1768

4. Blum JL, Jones SE, Buzdar AU (2001b) Capecitabine in 162 patients with paclitaxel-pretreated MBC: updated results and analysis of dose-modification. Eur J Cancer 37(Suppl 6): 190 (abstr. 693)

5. Blum JL, Jones SE, Buzdar AU, Lo Russo PM, Kuter I, Vogel C, Osterwalder B, Burger HU, Brown CS, Griffin T (1999) Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 17: 485–493

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of hand-foot syndrome and hand-foot skin reaction: Case series;TURKDERM;2019-04-04

2. Biomodulation of capecitabine by paclitaxel and carboplatin in advanced solid tumors and adenocarcinoma of unknown primary;Cancer Chemotherapy and Pharmacology;2015-09-28

3. Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial;European Journal of Cancer;2014-12

4. Efficacy and toxicity of Trastuzumab and Paclitaxel plus Capecitabine in the first-line treatment of HER2-positive metastatic breast cancer;J CANCER RES CLIN;2013

5. Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609;Cancer Chemotherapy and Pharmacology;2013-01-20